Max Robotics — Global Service Robot Directory + US Certification

About

Florian R. Schroeck is a leading urologic oncologist and health services researcher whose work has fundamentally shaped our understanding of the adoption, outcomes, and costs of advanced technologies in prostate cancer treatment. His research focuses on the comparative effectiveness of robotic-assisted laparoscopic prostatectomy versus open surgery, the diffusion of new technologies like intensity-modulated radiotherapy (IMRT), and their impact on patient satisfaction and healthcare economics. Schroeck’s seminal 2008 paper on satisfaction and regret after prostatectomy, cited over 370 times, revealed that patients undergoing robotic surgery were paradoxically more likely to experience regret, independent of side effects—a finding that challenged assumptions about technology-driven care. His 2013 study in JAMA, with 141 citations, demonstrated widespread use of advanced treatments in low-risk patients, raising critical questions about overtreatment. Schroeck has also systematically reviewed the costs of robotic surgery, IMRT, and proton therapy, providing essential data for value-based care. His work on surgical training showed that trainees do not compromise outcomes, supporting educational programs. Through these contributions, Schroeck has illuminated the complex interplay between innovation, patient expectations, and healthcare policy, making him a pivotal voice in evidence-based urologic oncology.